Page 30 - Belgian Act News Today : Breaking News, Live Updates & Top Stories | Vimarsana

  Unless the context otherwise requires, capitalised words and expressions used in this Announcement have the same meaning given to them in the announcement made by the Company earlier today in relation to the Issue.   Important Information This Announcement is an advertisement and does not constitute a prospectus relating to the Company and does not constitute, or form part of, any offer or invitation to sell or issue, or an invitation to purchase investments of any description, or any solicitation of any offer to subscribe for, any securities in the Company i...

Sequana Medical NV: Transparency Notifications from Shareholders Ghent, BELGIUM - 23 February 2021 - Sequana Medical NV (Euronext Brussels: SEQUA) (the " Company" or " Sequana Medical"), an innovator in the treatment of diuretic-resistant fluid overload in liver disease, malignant ascites and heart failure, announces today in accordance with Article 14 of the Belgian Act of 2 May 2007 on the disclosure of major participations in issuers of which shares are admitted to trading on a regulated market and regarding miscellaneous provisions (the " Belgian Transparency Act") that it received trans...

*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional bod...

Sequana Medical NV: SEQUANA MEDICAL'S NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES Ghent, Belgium, 16 February 2021 - Sequana Medical NV (Euronext Brussels: SEQUA) (the " Sequana Medical"), an innovator in the treatment of diuretic-resistant fluid overload in liver disease, malignant ascites and heart failure, announces, in accordance with Article 15 of the Belgian Act of 2 May 2007 on the disclosure of major participations in issuers of which shares are admitted to trading on a regulated market and regarding miscellaneous provisions, that in the context of the capital increase that was ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. The Capital Group holds 10.03% of Galapagos shares Galapagos NVFebruary 9, 2021 GMT Mechelen, Belgium; 9 February 2021; 22.01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received a new transparency notification from The Capital Group Companies, Inc. Pursuant to Belgian transparency legislation1, Galapagos received a transparency notification on 5 February 2021 from The Capital Group Companies, Inc., that it holds 10.03% of the current 65,411,767 outstanding Galapagos shares...